|
|
Volumn 16, Issue 11, 2007, Pages 2207-2212
|
|
Tamoxifen or raloxifene for breast cancer chemoprevention: A tale of two choices - point
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BLOOD CLOT;
BODY FAT;
BREAST CANCER;
CANCER PREVENTION;
CANCER SURVIVAL;
CATARACT;
CHEMOPROPHYLAXIS;
ENDOMETRIUM CANCER;
FOOD AND DRUG ADMINISTRATION;
HORMONE SUBSTITUTION;
HUMAN;
INTRACELLULAR KILLING;
POSTMENOPAUSE;
POSTMENOPAUSE OSTEOPOROSIS;
PREMENOPAUSE;
PRIORITY JOURNAL;
REVIEW;
RISK REDUCTION;
SIDE EFFECT;
SURVIVAL RATE;
SURVIVAL TIME;
ANTICARCINOGENIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
FEMALE;
HUMANS;
POSTMENOPAUSE;
RALOXIFENE;
TAMOXIFEN;
|
|
EID: 38849108639
PISSN: 10559965
EISSN: None
Source Type: Journal
DOI: 10.1158/1055-9965.EPI-07-0629 Document Type: Review |
|
Times cited : (18)
|
|
References (0)
|
